Cryptocurrency & Digital Assets

The biotech firm faces a delisting threat after its equity turned negative. Can recent funding save its Nasdaq spot and its ambitious drug pipeline?

FS Specialty Lending Fund declared a distribution yielding 11.7%. We explore the alternative credit strategy and risks behind this eye-catching income play.

As AGNC prepares its Q4 2025 earnings report, all eyes are on its dividend sustainability and risk strategies in a new era of Federal Reserve easing.

New rules will soon require frequent certificate renewals. A new partnership aims to help Aussie firms automate, as manual processes become impossible.

Adimab's stellar 2025 reveals its crucial role as the hidden tech platform driving drug discovery for giants like Lilly and Regeneron.

Cosmetics brand Sorevna is diving into the crowded bath and body sector, promising a revolutionary launch. But can its science-first approach succeed?

The Brazilian churrasco giant reveals plans for 14-16 new restaurants, pushing into new international markets and innovating beyond the grill.

As Vicenzaoro opens its sold-out 2026 show, the focus is on a new €60M pavilion, major industry trends, and its undisputed role as a global leader.

HEAVYS' new artist shells are more than an accessory; they're a statement of identity for music fans in an era of personalized, modular technology.

PrizePicks uses self-aware humor with Marshawn Lynch and Adam Devine to critique industry gimmicks, focusing on its simple, fan-first fantasy sports app.

A new partnership turns Samsung phones into secure payment terminals, offering an all-in-one business hub that could make traditional POS devices obsolete.

A new industry group aims to build trust in state-linked stablecoins by setting standards for disclosure and redemption, but is it self-regulation or a prelude to law?

Austrian firm AOP Health secures nationwide access for its rapid heart rate drug, Rapiblyk™, by partnering with top US distributors. What does this mean for critical care?

FirmTech is taking its AI-powered sexual wellness wearables worldwide, betting on data to revolutionize men's health. But can it navigate global privacy hurdles?

A historic $100M C-PACE loan funds a massive AI campus in Kansas City's iconic Star building, merging green finance with high-tech urban renewal.

The wellness firm secured a cash infusion by repricing options, a move that provides vital funds for its Zola brand but raises questions about dilution.

The legendary Southern chicken chain has landed in Brooklyn with a 24-hour drive-thru, testing its iconic flavors in NYC's competitive food scene.

NYU Langone and tech firm Tempus are launching a new protocol using serial DNA sequencing and AI to create hyper-personalized cancer treatments.

Petco is refinancing $1.5B in debt to extend maturities while reaffirming its financial outlook. Is this a sign of strength or underlying strain?

After a strategic pivot reverses a year of decline, Allurion's preliminary results show new growth. All eyes are now on the FDA for its 'procedureless' gastric balloon.